Angiographic Scores in Prediction of No-Reflow, Myocardial Injury May not end with Reperfusion.
作者信息
Tamazato Adriano Ossuna, Tamazato Thais Chang Valente, Bezerra Cristiano Guedes
机构信息
Hospitais Aliança, São Rafael, Cardiopulmonar - Rede D'Or, Salvador, BA - Brasil.
Hospital Ana Nery, Salvador, BA - Brasil.
出版信息
Arq Bras Cardiol. 2021 Mar;116(3):473-474. doi: 10.36660/abc.20210114.
Abstract
摘要
相似文献
1
Angiographic Scores in Prediction of No-Reflow, Myocardial Injury May not end with Reperfusion.血管造影评分在预测无复流方面的作用，心肌损伤可能不会随着再灌注而结束。
Arq Bras Cardiol. 2021 Mar;116(3):473-474. doi: 10.36660/abc.20210114.
2
Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow.血管造影无复流患者经皮冠状动脉腔内血管成形术后心肌挽救的定量评估
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):383-9. doi: 10.1007/s00259-002-1063-3. Epub 2002 Dec 19.
3
The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention.维拉帕米对直接经皮冠状动脉介入治疗后血管造影无复流患者心肌灌注恢复及功能恢复的影响。
Nucl Med Commun. 2006 Mar;27(3):247-54. doi: 10.1097/00006231-200603000-00007.
4
Coronary microvascular reperfusion injury and no-reflow in acute myocardial infarction.急性心肌梗死中的冠状动脉微血管再灌注损伤与无复流现象
Clin Invest Med. 2007;30(3):E133-45. doi: 10.25011/cim.v30i3.1082.
5
The value of the TIMI frame count method in the diagnosis of coronary no-reflow: a comparison with myocardial perfusion SPECT in patients with acute myocardial infarction.TIMI帧数法在冠状动脉无复流诊断中的价值：与急性心肌梗死患者心肌灌注单光子发射计算机断层扫描的比较
Nucl Med Commun. 2002 Dec;23(12):1205-10. doi: 10.1097/00006231-200212000-00009.
6
[Beneficial effects of ischemic preconditioning on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].[缺血预处理对小型猪急性心肌梗死及再灌注模型中心肌无复流的有益作用]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Aug;27(4):486-90.
7
[Reperfusion arrhythmias in acute myocardial infarction do not enhance myocardial injury].急性心肌梗死中的再灌注心律失常不会加重心肌损伤
Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Feb;35(2):164-7.
8
99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion.99m锝-甲氧基异丁基异腈在心肌缺血和再灌注期间的摄取与滞留。
Circulation. 1993 Jun;87(6):2033-42. doi: 10.1161/01.cir.87.6.2033.
9
Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy.中性粒细胞胞外诱捕网在缺血再灌注损伤诱导的心肌无复流中的作用：基于 DNA 酶的再灌注策略的治疗潜力。
Am J Physiol Heart Circ Physiol. 2015 Mar 1;308(5):H500-9. doi: 10.1152/ajpheart.00381.2014. Epub 2014 Dec 19.
10
Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction.再灌注期间的低温可限制兔急性心肌梗死模型中的“无复流”损伤。
Cardiovasc Res. 2003 Sep 1;59(3):715-22. doi: 10.1016/s0008-6363(03)00456-5.
本文引用的文献
1
Gensini Score and Thrombus Burden Add Predictive Value to the SYNTAX Score in Detecting No-Reflow after Myocardial Infarction.Gensini 评分和血栓负荷增加对 SYNTAX 评分检测心肌梗死后无复流的预测价值。
Arq Bras Cardiol. 2021 Mar;116(3):466-472. doi: 10.36660/abc.20200045.
2
The Usefulness of Admission Plasma NT-pro BNP Level to Predict Left Ventricular Aneurysm Formation after Acute ST-Segment Elevation Myocardial Infarction.入院时血浆氨基末端脑钠肽前体水平对预测急性 ST 段抬高型心肌梗死患者左心室室壁瘤形成的价值。
Arq Bras Cardiol. 2019 Dec;113(6):1129-1137. doi: 10.5935/abc.20190226.
3
A guide for Gensini Score calculation.Gensini评分计算指南。
Atherosclerosis. 2019 Aug;287:181-183. doi: 10.1016/j.atherosclerosis.2019.05.012. Epub 2019 May 10.
4
Comparative Analysis between Transferred and Self-Referred STEMI Patients Undergoing Primary Angioplasty.接受直接经皮冠状动脉介入治疗的转院和自行转诊 STEMI 患者的对比分析。
Arq Bras Cardiol. 2019 Apr;112(4):402-407. doi: 10.5935/abc.20190014. Epub 2019 Apr 15.
5
Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.直接经皮冠状动脉介入治疗 ST 段抬高型心肌梗死术后患者的微血管阻塞与不良事件的关系：来自七个随机试验的个体患者数据合并分析。
Eur Heart J. 2017 Dec 14;38(47):3502-3510. doi: 10.1093/eurheartj/ehx414.
6
Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry.经皮冠状动脉介入治疗（PCI）后短暂和持续无复流的长期临床结局：一项多中心澳大利亚注册研究。
EuroIntervention. 2018 Jun 20;14(2):185-193. doi: 10.4244/EIJ-D-17-00269.
7
Deferred Versus Immediate Stenting in Patients With ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.ST段抬高型心肌梗死患者延迟支架置入与直接支架置入的系统评价和Meta分析
J Am Heart Assoc. 2017 Mar 8;6(3):e004838. doi: 10.1161/JAHA.116.004838.
8
Management of No-Reflow Phenomenon in the Catheterization Laboratory.经导管实验室无复流现象的处理。
JACC Cardiovasc Interv. 2017 Feb 13;10(3):215-223. doi: 10.1016/j.jcin.2016.11.059.
9
The history of coronary reperfusion.
Eur Heart J. 2014 Oct 1;35(37):2510-5. doi: 10.1093/eurheartj/ehu268. Epub 2014 Jul 14.
10
A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).一项关于延迟支架置入术与即刻支架置入术预防急性ST段抬高型心肌梗死无复流或慢血流的随机试验（DEFER-STEMI）
J Am Coll Cardiol. 2014 May 27;63(20):2088-2098. doi: 10.1016/j.jacc.2014.02.530. Epub 2014 Feb 27.
Zotero 插件